Advisor Resource Council

Position in ROIV — Roivant Sciences Ltd.

CIK 1820879 DALLAS, TX

Position in ROIV

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$245,217

New position

Shares Held

6,929

first reported quarter

Ownership

0.001%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#341

of 494 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Advisor Resource Council holds $1,698,942 across 4 Biotechnology names. ROIV ranks #3 (14.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	16,003	$897,288
2	LGND	Ligand Pharmaceuticals Inc	1,147	$362,555
3	ROIV	Roivant Sciences Ltd. This page	6,929	$245,217
4	AUPH	Aurinia Pharmaceuticals Inc.	11,425	$193,882

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$245,217	6,929	—	Shares	Sole	2026-07-28
No filing history on record for this holder in this stock.